A Sustainable Investment in Journalism

A sustainable business requires diverse revenue streams. ESG Investor now operates a subscription service as of Tuesday 14th May. To find out more please get in touch with our subscription team on subscriptions@esginvestor.net


“Pervasive” Patent Thickets Conceal Pharma’s Intentions

Shareholder proposals at 2023 AGMs seek clarity on patent practices by large US drug companies, ensuring innovations are driven by science rather than profit. 

The filing of seven shareholder proposals at US pharmaceutical firms request reports on how patents impact patients’ access to medicines and address non-competitive practices permitted by the “pervasive” issue of patent thickets.   The Interfaith Center on Corporate Responsibility (ICCR), a coalition of over 300 global institutional investors advocating for corporate…

To continue reading...


Subscribe to ESG Investor to gain access to the leading platform for news, analysis, and interviews across sustainable investing. Select subscribe below to view our subscription packages or you can email us at subscriptions@esginvestor.net to discuss your options.


Request a Trial

Get in touch today to discuss a trial giving you unrestricted and unlimited access to ESG Investor for you and/or your team(s) for a limited period. Email us at subscriptions@esginvestor.net

The practical information hub for asset owners looking to invest successfully and sustainably for the long term. As best practice evolves, we will share the news, insights and data to guide asset owners on their individual journey to ESG integration.

Copyright © 2024 ESG Investor Ltd. Company No. 12893343. ESG Investor Ltd, Fox Court, 14 Grays Inn Road, London, WC1X 8HN

To Top
Share via
Copy link
Powered by Social Snap